NEW YORK (GenomeWeb News) – Nanogen today reported that total revenues for the second quarter of 2008 grew 25 percent to $12.9 million from $10.3 million in the year-ago period, while its loss fell by 65 percent.
 
Nanogen posted a 51 percent increase in product revenues for the quarter ended June 30, to $8 million from $5.3 million recorded in the comparable period of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.